About
Former hematologist, Professor Emeritus of Therapeutics, Sorbonne-Paris Nord University; Member of AFIS (French Association for Scientific Information)
Most viewed articles
The French and unconventional medical practices: What to do?
In Médecine (2025/10 Vol. 21)
The safety-based approach means there is an urgent need for public psychiatry
In Médecine (2023/7 No 47)
Experience or scientific validation in the doctor’s therapeutic decision?
Experience or scientific validation in the doctor’s therapeutic decision?
In Médecine (2025/8 Vol. 21)
Communicating with your patient about scientific truth
In Médecine (2026/1 Vol. 22)
Should physical activity be recommended to all women?
In Médecine (2023/8 Vol. 19)
Co-authors
Articles
Communicating with your patient about scientific truth
In Médecine (2026/1 Vol. 22)
The French and unconventional medical practices: What to do?
In Médecine (2025/10 Vol. 21)
Messenger RNA COVID-19 vaccines: Unexpected benefits rather than fears!
Le concept des vaccins à ARN messager (ARNm) et leur rapidité de production
In Médecine (2025/10 Vol. 21)
Experience or scientific validation in the doctor’s therapeutic decision?
Experience or scientific validation in the doctor’s therapeutic decision?
In Médecine (2025/8 Vol. 21)
Deprescribing: The end of a taboo?
- By Patrice Queneau
- and Philippe Casassus
In Médecine (2025/8 Vol. 21)
Artificial intelligence (AI) and medicine: Hopes and precautions
In Médecine (2025/8 Vol. 21)
In the press
In Médecine (2025/7 Vol. 21)
Trumped up decisions and their consequences on the field of global health
In Médecine (2025/4 Vol. 21)
In the press
In Médecine (2025/3 Vol. 21)
What should we know about physical activity among older populations?
In Médecine (2024/10 Vol. 20)
Press releases
In Médecine (2024/9 Vol. 20)
A little bit of perspective on COVID-19 vaccination
Part Two: Summary of public health findings and controversies over adverse effects
In Médecine (2024/9 Vol. 20)
A broader perspective on the COVID-19 vaccination
Part 1: Initial studies on these vaccines.
In Médecine (2024/8 Vol. 20)
How to make the best therapeutic choice during your consultation?
In Médecine (2024/8 Vol. 20)
Patients’ words
In Médecine (2024/6 Vol. 20)
In the press
In Médecine (2024/5 Vol. 20)
EBM and alternative medicine: What to make of it?
In Médecine (2024/2 Vol. 20)
The challenges of “touch” and intimacy in clinical examination
In Médecine (2024/1 Vol. 20)
In the press
In Médecine (2024/1 Vol. 20)
How should thrombotic events linked to COVID-19 vaccines be understood?
In Sang Thrombose Vaisseaux (2024/1 Volume 36)
Should physical activity be recommended to all women?
In Médecine (2023/8 Vol. 19)
The safety-based approach means there is an urgent need for public psychiatry
In Médecine (2023/7 No 47)
Press releases
In Médecine (2023/7 No 47)
The revolution in hemato-oncological treatments and the hopes brought by new concepts
Part 2: Targeted therapies and immunotherapy
In Médecine (2023/4 No 44)
The end of life: Relentlessness, assisted suicide, euthanasia, palliative care . . . where are we heading?
- By Philippe Casassus
- and Patrice Queneau
In Médecine (2023/4 No 44)
The revolution in hemato-oncological treatments and the hopes brought by new concepts
Part 1: The time of chemotherapy
In Médecine (2023/3 No 43)
Press releases
In Médecine (2023/3 No 43)
In the press
In Médecine (2022/9 Vol. 18)
The slow evolution from belief to evidence: Can history of medicine help us to understand somatoform disorder, hypochondria, and organic disease?
In Médecine (2022/8 Vol. 18)
An investigation on “Long COVID”
- By Philippe Casassus
- and Éric Drahi
In Médecine (2022/6 Vol. 18)
In the press
In Médecine (2022/5 Vol. 18)
From the Great Plague of Marseille to COVID-19: Epidemic responses
In Médecine (2022/1 Vol. 18)